13 August 2018
Lunch Seminar at IMSC 2018: Register Today!Target Deconvolution (LiP)
Our Limited Proteolysis technology, coupled with mass spectrometry (LiP-MS) detects protein conformational changes.
Biognosys - Next Generation Proteomics
Why proteomics?
Proteomics aims at understanding the proteome by enabling the unbiased and large-scale study of proteins. Watch the video to understand why next generation proteomics should be the technology of choice in studies involving multiplexed protein quantification.
The Science hub is a library that contains scientific and technical information
related to Biognosys technology, products and services.
Start exploring the Science hub >>
BIOGNOSYS
NEWS
03 August 2018
Join Biognosys at IMSC 2018!
27 July 2018
Our Latest Research from ASMS 2018
Go to news archive.
Go to conference calendar
Biognosys in the world
Biognosys maintains its global presence with two offices worldwide, a headquarters in Zurich, Switzerland and an US office in Boston, MA.
Contact us
| Biognosys AG Wagistrasse 21 8952 Schlieren Switzerland |
Biognosys Inc Judge Science Center
376 Hale Street Beverly, MA 01915 USA
|
Phone: +41 44 738 20 40
Fax: +41 44 738 20 48
Email: info@biognosys.com (general inquiries)
Email: sales@biognosys.com (sales or product/service related inquiries, such as pricing, quotes etc.)
What is Biognosys
We believe that the decoding of the proteome will impact life science more than the genome revolution a decade ago. We provide innovative services and products for protein quantification using cutting edge technology. We strive to be the company that provides the best possible solutions to support researchers in their protein analysis needs.
A new generation of protein quantification technology
"Revolutions in science have often been preceded by revolutions in measurement" (Sinan Aral, NYU)
Our next generation technology quantifies proteins with unbeatable precision and depth. The solution is based on mass spectrometry based targeted proteomics technology, which provides simultaneous quantification for thousands of proteins in a single experiment.
Our Mission: Providing superior proteomics solutions to researchers
We at Biognosys are more than our own research. We make next-generation proteomics widely available with our contract research services and with our portfolio of innovative reagent and software products. Biognosys was founded in 2008 and is a privately held company in Zurich, Switzerland. Originally an ETH Zurich spin-off from the lab of Prof. Ruedi Aebersold, Biognosys is a pioneer in the field of proteomics and caters to the Pharma, Biotech, Diagnostics and Agricultural industries.
